Cargando…

Dupuytren’s disease: using needles more across the world

In this article we take an international perspective on the use of needles, either percutaneous needle fasciotomy (PNF) or Clostridial Collagenase Histiolyticum (CCH), in treating Dupuytren’s Disease (DD). Worldwide, PNF is now used more frequently. The CCH has been withdrawn from non-USA markets, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Warwick, David, NM Werker, Paul, Pess, Gary, Hirata, Hitoshi, Hunter-Smith, David J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721555/ https://www.ncbi.nlm.nih.gov/pubmed/34496664 http://dx.doi.org/10.1177/17531934211043307

Ejemplares similares

Matrix and cell phenotype differences in Dupuytren’s disease
por: van Beuge, Marike M., et al.
Publicado: (2016)

Imaging for Dupuytren disease: a systematic review of the literature
por: Molenkamp, Sanne, et al.
Publicado: (2019)

Incidence of Tendon Rupture After Collagenase Clostridium Histolyticum Injection for Treatment of Dupuytren Contracture in Adults: A Postmarketing Safety Analysis
por: Peimer, Clayton A., et al.
Publicado: (2022)

Further evidence of the involvement of the Wnt signaling pathway in Dupuytren’s disease
por: ten Dam, Evert-Jan P. M., et al.
Publicado: (2015)

Patient-Perceived Hand Function Can Predict Treatment for Dupuytren Disease
por: van den Berge, Bente A., et al.
Publicado: (2023)

Ethnic differences in prevalence of Dupuytren disease can partly be explained by known genetic risk variants
por: Riesmeijer, Sophie A., et al.
Publicado: (2019)

Echogenicity of Dupuytren’s nodules is correlated to myofibroblast load and nodule hardness
por: Molenkamp, Sanne, et al.
Publicado: (2021)

Clinical Results of Percutaneous Needle Fasciotomy for Dupuytren’s Disease in Japanese Patients
por: Abe, Yoshihiro, et al.
Publicado: (2015)

Dupuytren’s disease is a work-related disorder: results of a population-based cohort study
por: van den Berge, Bente A., et al.
Publicado: (2023)

Verteporfin ameliorates fibrotic aspects of Dupuytren’s disease nodular fibroblasts irrespective the activation state of the cells
por: Puerta Cavanzo, Nataly, et al.
Publicado: (2022)

Versatility of percutaneous needle fasciotomy for Dupuytren's disease across a spectrum of disease severity: A single-surgeon experience of 118 rays
por: Patel, Manal I.A., et al.
Publicado: (2020)

A Systematic Review and Meta-Analysis on the Strength and Consistency of the Associations between Dupuytren Disease and Diabetes Mellitus, Liver Disease, and Epilepsy
por: Broekstra, Dieuwke C., et al.
Publicado: (2018)

A Genome-wide Association Study of Dupuytren Disease Reveals 17 Additional Variants Implicated in Fibrosis
por: Ng, Michael, et al.
Publicado: (2017)

Paediatric Dupuytren's disease
por: Korambayil, Pradeoth Mukundan, et al.
Publicado: (2011)

Clinical and morphological outcomes after percutaneous needle fasciotomy in Dupuytren’s disease according to the contracture severity
por: Trâmbiţaş, Cristian, et al.
Publicado: (2021)

Dupuytren Disease: A Retrospective Cohort Study Comparing Collagenase Injection and Percutaneous Needle Fasciotomy
por: Mehdiyev, Turkhan, et al.
Publicado: (2022)

Needle Fasciotomy or Collagenase Injection in the Treatment of Dupuytren’s Contracture: A Retrospective Study
por: Abdelrahman, Islam, et al.
Publicado: (2020)

A Weighted Genetic Risk Score Predicts Surgical Recurrence Independent of High-Risk Clinical Features in Dupuytren’s Disease
por: Riesmeijer, Sophie A., et al.
Publicado: (2019)

Acute Pain Intensity After Collagenase Clostridium histolyticum Injection in Patients With Dupuytren Contracture
por: Noto, Kimitoshi, et al.
Publicado: (2019)

Sorafenib in Dupuytren and Ledderhose Disease
por: Schoenfeld, Joshua D, et al.
Publicado: (2022)

Molecular mechanisms and treatment strategies for Dupuytren’s disease
por: O’Gorman, David B, et al.
Publicado: (2010)

Comparative Effectiveness of Needle Aponeurotomy and Collagenase Injection for Dupuytren’s Contracture: A Multicenter Study
por: Zhou, Chao, et al.
Publicado: (2017)

Epidermal Inclusion Cysts following Dupuytren’s Percutaneous Needle Fasciotomy: A Case Report
por: Turner, Jessica, et al.
Publicado: (2021)

The prevalence of Dupuytren’s disease in patients with diabetes mellitus
por: Ganesan, Sandhya, et al.
Publicado: (2023)

Dupuytren's Contracture
por: Sood, Aditya, et al.
Publicado: (2013)

Dupuytren's contracture
por: Raina, Sujeet, et al.
Publicado: (2012)

Dupuytren's Disease: the Vikings Disease in Koreans
por: Gong, Hyun Sik
Publicado: (2018)

Measurement properties of the Dutch Unité Rhumatologique des Affections de la Main and its ability to measure change due to Dupuytren’s disease progression compared with the Michigan Hand outcomes Questionnaire
por: Broekstra, Dieuwke C., et al.
Publicado: (2018)

Percutaneous needle fasciotomy for Dupuytren's disease: A one-stop approach incidentally suited to the era of COVID-19()
por: Patel, Manal I., et al.
Publicado: (2020)

Real-world Medicare Healthcare Costs of Patients with Dupuytren’s Contracture Treated with Collagenase or Fasciectomy
por: Zah, Vladimir, et al.
Publicado: (2022)

Evaluation of surgical treatment of Dupuytren's disease by modified open palm technique()()
por: Guilhen, Thiago Almeida, et al.
Publicado: (2014)

A randomised feasibility trial comparing needle fasciotomy with limited fasciectomy treatment for Dupuytren’s contractures
por: Davis, T. R. C., et al.
Publicado: (2020)

Microfasciectomy in Dupuytren’s disease: microsurgery in the evolution toward safer and more efficient fasciectomy and hand surgery
por: Degreef, Ilse, et al.
Publicado: (2023)

Use of Acellular Dermal Matrix Following Fasciectomy for the Treatment of Dupuytren’s Disease
por: Hoang, Don, et al.
Publicado: (2019)

Dupuytren's Disease: Review of the Current Literature
por: Khashan, Morsi, et al.
Publicado: (2011)

Dupuytren's: a systems biology disease
por: Rehman, Samrina, et al.
Publicado: (2011)

The Rationale for Treating the Nodule in Dupuytren’s Disease
por: Ketchum, Lynn D.
Publicado: (2015)

Dupuytren’s disease and the risk of malignant neoplasms
por: Żyluk, Andrzej, et al.
Publicado: (2014)

Cytokine Targeted Therapy for Dupuytren's Disease
por: Satish, Latha
Publicado: (2018)

Epidemiological analysis of patients with Dupuytren's disease()
por: Mansur, Henrique Gonçalves, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9flilme2ablb6o3a5hl4jrkk7k